RAC 3.17% $1.53 race oncology ltd

Ann: Bisantrene Phase 2 AML Trial Successful Concludes, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,027 Posts.
    lightbulb Created with Sketch. 313
    This is the one of the closest to a sure thing I can find in the madly speculative bio tech industry.
    Proven drug knocking it out of the park as a repurposed and reformulated medicine.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.53
Change
-0.050(3.17%)
Mkt cap ! $259.9M
Open High Low Value Volume
$1.58 $1.59 $1.51 $174.6K 113.0K

Buyers (Bids)

No. Vol. Price($)
1 2372 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.59 141 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.